用生物材料修复胸壁和隔膜的长期结果
Hayan Merhej1, Mohammed Ali1, Tomoyuki Nakagiri1
1Department of Cardiothoracic Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Niedersachsen, Germany.
The Thoracic and cardiovascular surgeon
|November 1, 2023
概括
脱细胞化牛心膜是可用于胸壁和腹膜重建的可行的移植物,在长达十年的研究中没有显示30天的死亡率和可控的发病率.
科学领域:
- 胸部外科手术 胸部外科手术
- 生物材料科学是生物材料的科学.
- 再生医学是一种再生医学.
背景情况:
- 胸壁和隔膜重建的目的是恢复呼吸功能和支持.
- 使用各种移植材料,包括合成和生物选择.
- 这项研究回顾了十多年来使用脱细胞化牛心膜的情况.
研究的目的:
- 评估脱细胞化牛心膜在胸壁和隔膜重建中的有效性和安全性.
- 分析患者的结果,并发症和长期随访.
- 评估移植体大小和术后并发症之间的相关性.
主要方法:
- 71名患者的回顾性分析,这些患者接受了乳房壁/隔膜修复,用脱细胞化牛心周 (2012-2022年).
- 数据收集包括患者特征,并发症,治疗持续时间,住院和死亡率.
- 在手术后至少2个月收集的后续信息.
主要成果:
- 71名患者接受了重建 (胸壁,腹膜或心周).
- 没有观察到30天死亡率.
- 12名患者的主要发病率 (呼吸衰竭,感染);手术程度和呼吸道并发症之间没有相关性.
结论:
- 脱细胞化牛心膜证明了作为生物移植材料的持续生存能力.
- 长期的结果支持在各种重建程序中使用它.
- 这项研究加强了生物材料在胸部重建中的有效性.
更多相关视频
10:52Laparoscopic Repair of Para-Esophageal Hernia Using Absorbable Biosynthetic Mesh
Published on: September 11, 2021
5.3K
00:20A Case Series of Successful Abdominal Closure Utilizing a Novel Technique Combining a Mechanical Closure System with a Biologic Xenograft that Accelerates Wound Healing
Published on: July 4, 2019
51.3K
相关概念视频
01:26Flail Chest-II
184
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
184
01:27Pneumothorax-II
168
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
168